เจาะลึกการเติบโตของตลาดเครื่องมือแพทย์ในเม็กซิโกซึ่งคาดว่าจะมีมูลค่าถึง 12.6 พันล้านดอลลาร์สหรัฐภายในปี 2029 ตอนนี้จะเน้นไปที่การเปลี่ยนแปลงกฎระเบียบครั้งสำคัญของ COFEPRIS เกี่ยวกับเส้นทางด่วนในการขึ้นทะเบียน (Abbreviated Regulatory Pathway) ที่จะมีผลในเดือนกันยายน 2025 ซึ่งจะช่วยลดระยะเวลาการอนุมัติสำหรับผู้ผลิตที่ได้รับการรับรองจากหน่วยงานสากลที่เชื่อถือได้- ตลาดเครื่องมือแพทย์ของเม็กซิโกมีศักยภาพการเติบโตสูงเพียงใด? -

Tập này đi sâu vào tiềm năng tăng trưởng bùng nổ của thị trường thiết bị y tế Mexico, dự kiến đạt 12.6 tỷ USD vào năm 2029. Chúng tôi phân tích các yếu tố thúc đẩy chính như chi tiêu y tế gia tăng, dân số già hóa, và nhu cầu nhập khẩu lên tới 90%, tạo ra cơ hội lớn cho các nhà sản xuất quốc tế.- Tại sao thị trường thiết bị y tế Mexico được dự báo sẽ tăng trưởng 7.6% mỗi năm cho đến 2029? - Những yếu tố nhân khẩu học và kinh tế nào đang thúc đẩy sự phát triển này? - Tại sao việc Mexico nhập khẩu

Bu bölümde, Meksika medikal cihaz pazarının neden uluslararası üreticiler için göz ardı edilemeyecek bir fırsat sunduğunu inceliyoruz. 2024-2029 yılları arasında öngörülen %7.6'lık etkileyici büyüme oranı, pazarın 12.6 milyar dolarlık bir değere ulaşma potansiyelini ortaya koyuyor. Artan sağlık harcamaları, yaşlanan nüfus ve kronik hastalıklardaki yükseliş gibi temel itici güçleri analiz ediyor ve pazarın %90 oranında ithalata dayalı olmasının küresel şirketler için ne anlama geldiğini

I det här avsnittet dyker vi djupt ner i den mexikanska marknaden för medicinteknik, en av de snabbast växande i Latinamerika. Vi analyserar prognosen som förutspår en marknad värd 12,6 miljarder dollar år 2029, driven av en årlig tillväxt på 7,6 % mellan 2024 och 2029. Lyssna för att förstå de viktigaste drivkrafterna, såsom en åldrande befolkning och ett starkt importberoende, och hur ditt företag kan positionera sig för att lyckas på denna lukrativa marknad.- Varför förväntas Mexikos marknad

यह एपिसोड मेक्सिको के तेजी से बढ़ते चिकित्सा उपकरण (medical device) बाजार का विश्लेषण करता है। हम 2024 से 2029 तक 7.6% की अनुमानित वृद्धि दर, $12.6 बिलियन के बाजार आकार, और इस विस्तार के पीछे के प्रमुख कारकों, जैसे बढ़ती स्वास्थ्य सेवा खर्च, उम्रदराज आबादी, और पुरानी बीमारियों की व्यापकता पर चर्चा करते हैं। जानें कि क्यों 90% आयात निर्भरता अंतरराष्ट्रीय निर्माताओं के लिए एक सुनहरा अवसर प्रदान करती है और COFEPRIS नियामक परिदृश्य को कैसे नेविगेट करें।- मेक्सिको का चिकित्सा उपकरण बाजार 2029 तक $12.6

Questo episodio analizza l'enorme potenziale del mercato messicano dei dispositivi medici, destinato a una crescita esplosiva. Esploriamo i fattori chiave che guidano questa espansione, tra cui l'aumento della spesa sanitaria, i cambiamenti demografici e la forte dipendenza dalle importazioni, che rappresenta un'opportunità unica per i produttori internazionali. - Perché il mercato messicano dei dispositivi medici è considerato una frontiera chiave per il 2024-2029? - Qual è il tasso di crescita

Este episódio explora o mercado mexicano de dispositivos médicos em rápido crescimento, projetado para atingir 12,6 mil milhões de dólares até 2029. Analisamos os principais impulsionadores do crescimento, a alta procura por dispositivos importados e os requisitos regulatórios essenciais estabelecidos pela COFEPRIS, incluindo o papel crucial de um Titular de Registo no México (MRH) e a vantagem estratégica da Rota de Equivalência. - O que está a impulsionar o crescimento anual de 7,6% no mercado de

Cet épisode explore l'opportunité de croissance significative que représente le marché mexicain des dispositifs médicaux. Nous analysons les projections qui estiment que le marché atteindra 12,6 milliards de dollars d'ici 2029, avec un TCAC de 7,6 %. Nous discutons des principaux moteurs de cette croissance, notamment l'augmentation des dépenses de santé et les changements démographiques, ainsi que de l'immense opportunité pour les fabricants internationaux due à une dépendance de 90 % aux

In this episode of Molecule to Market, you’ll hear wily old wisdom, golden nuggets and invaluable insider tips about CPHI. The nuanced stuff from Veterans of CPHIs gone by you’ll never find in a generic AI-written playbook. The show features:James West, Managing Director, Bourne Partners Arul Ramadurai, CCO at Axplora Christine Fuerst, Director Key Account Management Europe, Vetter Pharma International GmbH Dan Stanton, leading pharma/biopharma industry journalist Jeremy Drummond PhD, retired VP

Podcastimizin 103. bölümünde başlığımız “Akrabalık İlişkileri ve Kişiliğimize Etkileri” oldu. Beğeneceğinizi umuyoruz, iyi seyirler.

This is a free preview of a paid episode. To hear more, visit www.razibkhan.comToday, Razib talks to Coltan Scrivner, a behavioral scientist, horror entertainment producer, and author, whose work centers on the psychological and evolutionary roots of our fascination with darkness, horror, and true crime. He is affiliated with the Department of Psychology at Arizona State University. Scrivner also serves as the executive director of the Nightmare in the Ozarks Film Festival and founded the Eureka

Dr. Don and Professor Ben talk about the risks from consuming opened organic lemonade refrigerated for 4 weeks. Dr. Don - not risky 👍🏼  Professor Ben - not risky 👍🏼   Kirkland Signature, Organic Lemonade, 96 fl oz, 2-Count | Costco mycotoxin fruit juice - Google Scholar Mycotoxins in Fruits, Fruit Juices, and Dried Fruits - ScienceDirect Ochratoxin A in beverages from Morocco: a preliminary survey: Food Additives and Contaminants: Vol 18 , No 6

★毎週土曜日、夜10：30に配信！ ★ 「ドリームハート 」の番外編番組 「茂木健一郎のポジティブ脳教室 」 ここでは リスナーの皆様から寄せられたお悩みやご質問に 茂木健一郎さんが 脳科学 的にお答えし「ポジティブな考え方」を 伝授していきます！ 今夜は 東京都の「ラジオネーム 小3のママ」さんからのメッセージ。 =========================================== 小学3年生の娘が 「みんな持ってるからスマホほしい」 …と言い始めました。 連絡手段としては便利だと思いますが SNSや動画の見過ぎが心配です。 最初は家だけで使うルールから始めるのが良いのでしょうか。 また若いうちかスマホを使うことで 脳への影響などあるのでしょうか？ 年齢に合った始め方を教えてほしいです。 =========================================== 今週は こちらのお悩みにお答えしていきます。 茂木さんに聞いて欲しい疑問・質問、お悩みやご相談など… 全てのメッセージは 毎週土曜日の夜10時から

👉 Para receber diretamente os áudios no seu celular, entre para o grupo: 🔗 https://site.vedanta.com.br/lead/cast-jz Saiba mais sobre esse conhecimento em: https://www.instagram.com/vedanta.soma

Can you imagine parents expecting a baby, going in for an ultrasound, and finding out that their baby is missing the heart's left ventricle? This week on BioTech Nation, Dr. Joshua Hare, Co-Founder and Chief Scientific Officer of Longeveron, talks about how they are testing the use of stem cells to treat babies born with a serious congenital heart defect.

In this classic episode of Weirdhouse Cinema, Rob and Joe keep the terror train rolling down the tracks with a look at the 1972 sci-fi thriller "Horror Express," starring Christopher Lee, Peter Cushing, Alberto de Mendoza, Silvia Tortosa and Telly Savalas. (originally published 10/4/2024)See omnystudio.com/listener for privacy information.

AI is everywhere these days, and though there’s debate about how useful it is, one area where experts think it could be game-changing is scientific research. It promised to be particularly useful for speeding up drug discovery, an expensive and time-consuming process that can take decades. But so far, it hasn’t panned out.The few AI-designed drugs that have made it to clinical trials haven’t been approved, venture capital investment in these efforts has cratered in the last few years, and many

This episode is published by the Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).Thanks for listening and enjoy

This episode is published by the Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).Thanks for listening and enjoy

Human-specific duplicates of SRGAP2 prolong cortical development by manipulating SYNGAP, an autism-linked protein that slows synaptic growth.